VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX)

CUSIP: G9495L109

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Stock
Total 13F shares
58,373
Share change
+58,373
Total reported value
$183,000
Price per share
$3.13
Number of holders
4
Value change
+$183,000
Number of buys
4

Quarterly Holders Quick Answers

What is CUSIP G9495L109?
CUSIP G9495L109 identifies VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX) as of Q3 2022

As of 30 Sep 2022, VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,373 shares. The largest 4 holders included Schonfeld Strategic Advisors LLC, UBS Group AG, BANK OF AMERICA CORP /DE/, and Tower Research Capital LLC (TRC). This page lists 4 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.